HbA1c, Coronary atheroma progression and cardiovascular outcomes.

Dykun, Iryna; Bayturan, Ozgur; Carlo, Julie; Nissen, Steven E; Kapadia, Samir R; Tuzcu, E Murat; Nicholls, Stephen J; Puri, Rishi

Dykun, Iryna; Bayturan, Ozgur; Carlo, Julie; Nissen, Steven E; Kapadia, Samir R; Tuzcu, E Murat; Nicholls, Stephen J; Puri, Rishi.

Afiliação

Dykun I; C5Research, Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH.
Bayturan O; Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.
Carlo J; Department of Cardiology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.
Nissen SE; C5Research, Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH.
Kapadia SR; C5Research, Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH.
Tuzcu EM; C5Research, Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH.
Nicholls SJ; Department of Cardiovascular Medicine, Cleveland Clinic Abu Dhabi, UAE.
Puri R; Monash Cardiovascular Research Centre, Victorian Heart Institute, Monash University, Melbourne, Australia.

Am J Prev Cardiol ; 9: 100317, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35112095

Palavras-chave

ACS, acute coronary syndrome; AQUARIUS, Aliskiren Quantative Atherosclerosis Regression Intravascular Ultrasound Study; ASCVD, atherosclerotic cardiovascular disease; BMI, body mass index; CVD, cardiovascular disease; Coronary atheroma progression; Diabetes mellitus; GLAGOV, Global Assessment of Plaque Regression With a PCSK9 Antibody as Measured by Intravascular Ultrasound; HDL-C, high-density lipoprotein cholesterol; HbA1c; HbA1c, hemoglobin A1c; IBIS 2, The Integrated Biomarkers and Imaging Study-2; IVUS; IVUS, intravascular ultrasonography; LDL-C, lipoprotein cholesterol; MACE; MACE, major adverse cardiovascular events; NORMALISE, Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation; PAV, percent atheroma volume; PERISCOPE, Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation; PVD, peripheral vascular disease; REVERSAL, Reversal of Atherosclerosis With Aggressive Lipid Lowering; SATURN, The Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin; STRADIVARIUS, Strategy to Reduce Atherosclerosis Development Involving Administration of Rimonabont The Intravascular Ultrasound Study; TG, triglycerides; UKPDS, UK Prospective Diabetes Study; hsCRP, high-sensitivity-CRP

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Prev Cardiol Ano de publicação: 2022 Tipo de documento: Article País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google